Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 5/20 | 0.61 |
| ▸ | FAAH | O00519 | 1/20 | 0.55 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | MC4R | P32245 | 1/20 | 0.52 |
| ▸ | DRD4 | P21917 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | ACHE | P22303 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2902591 | 0.82 | SIGMAR1 (0.52) | SIGMAR1FAAHCYP2D6MC4RDRD4 | |
| SCHEMBL102338 | 0.80 | SIGMAR1 (0.71) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL6200777 | 0.80 | SIGMAR1 (0.71) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL28158277 | 0.79 | SIGMAR1 (0.68) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL948372 | 0.79 | SIGMAR1 (0.68) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL896379 | 0.79 | SIGMAR1 (0.68) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL18065638 | 0.79 | SIGMAR1 (0.68) | SIGMAR1MC4RDRD4LMNAPOLB | |
| Water SCHEMBL1702298 | 0.79 | SIGMAR1 (0.68) | SIGMAR1MC4RDRD4LMNAPOLB | |
| Hydrochloric Acid SCHEMBL6261135 | 0.79 | SIGMAR1 (0.68) | SIGMAR1MC4RDRD4LMNAPOLB | |
| SCHEMBL1415730 | 0.77 | SIGMAR1 (1.00) | SIGMAR1MC4RDRD4LMNAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9951179-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-9951179-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2018-04-24 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2017-06-08 | — | — | US | disclosed |
| US-9624191-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9622476-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9622476-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9622476-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-9624191-B2 | Cyclic carbonate monomers and ring opened polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2017-04-18 | — | — | US | disclosed |
| US-20160081343-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2016-03-24 | — | — | US | disclosed |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-14 | — | — | US | disclosed |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-14 | — | — | US | disclosed |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-01-14 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-9215876-B2 | 1,3,6-dioxazocan-2-ones and antimicrobial cationic polycarbonates therefrom | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 2015-12-22 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2015-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150264932-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | WEE1, WEE2, THEM6 | SIGMAR1 930/4885FAAH 4785/4885CYP2D6 857/4885 |
| US-20160009860-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | ACMSD, CARM1, PBRM1 | SIGMAR1 1218/4885FAAH 2418/4885CYP2D6 3824/4885 |
| US-20160081343-A1 | 1,3,6-DIOXAZOCAN-2-ONES AND ANTIMICROBIAL CATIONIC POLYCARBONATES THEREFROM | WEE1, WEE2, THEM6 | SIGMAR1 930/4885FAAH 4785/4885CYP2D6 857/4885 |
| US-20170158811-A1 | CYCLIC CARBONATE MONOMERS AND RING OPENED POLYCARBONATES THEREFROM | ACMSD, CARM1, PBRM1 | SIGMAR1 1218/4885FAAH 2418/4885CYP2D6 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.